International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.8054466
Original Article
A Prospective Observational Study to Determine Causes of Anemia in Intensive Care Unit Patients
 ,
 ,
Published
June 19, 2023
Abstract
Anaemia is commonly seen in critically ill patients and is associated with considerable morbidity and worse outcomes. Common factors responsible for development of anemia during their stay in ICU are due to blood loss, nutritional deficiency, drug induced, phlebotomy and defective or decreased erythropoiesis etc. Aims: This study aimed to determine the causes of anemia and to analyzehematological, biochemical, and clinical pathological parameters from ICU patients. Methods and Material: Prospective observational study of 300 adult patients admitted to the ICU with stay of more than 7 days. Details such as age, sex, and clinical history (history of phlebotomy and blood transfusion) was obtained. Hemogram, PBS and other parameters (imaging, biochemistry, microbiology, serology) were studied. Results: Out of the 300 patients discharged with anemia, 266 had anemia at admission and 34 developed anemia during ICU stay. Most common cause of admission to ICU was medical followed by surgery and trauma. 65 patients had shock at admission. Lowest mean Hb was 7.13 g/dl seen in septic cases, most common type of morphological anemia at admission was NCNC. Anemia worsened in 101 patients, with male (64) predominance. 8 patients with worsened anaemia did not survive. Conclusions: Anemia is a significant cause of morbidity in critically ill patients specially in background of sepsis, post operative period and chronic renal diseases.
Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
1013 Views
235 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved